Steven M. Rosato

Steve’s recent experience includes the following:

• Representing a Fortune 100 global biopharmaceutical company in several litigations arising out of contingent value rights (“CVRs”) issued in connection with the company’s acquisition of another major biopharmaceutical company.  To date, Steve has achieved complete dismissal of a consolidated federal securities class action in the US District Court for the Southern District of New York, which was recently affirmed on appeal by the US Court of Appeals for the Second Circuit.  Steve also won complete dismissal of related putative securities class actions asserting claims under the Securities Act of 1933 in New York and New Jersey state court.  Steve also was instrumental in achieving dismissal of related litigation in the Southern District of New York alleging breach of the underlying contract governing the CVRs (currently on appeal to the Second Circuit), and continues to represent the client in follow-on litigation stemming from that dismissal 
• Representing a publicly traded renewable energy company focused on hydroelectric power generation and delivery in a consolidated federal securities class action in the US District Court for the Northern District of New York and in related stockholder derivative litigation in Delaware
• Representing a cutting-edge fintech company in a putative federal securities class action in the US District Court for the District of New Jersey, as well as in related state-court litigation initiated by a significant investor in a publicly traded business partner of the company 
• Representing underwriters of a secondary public offering in a putative federal securities class action in the US District Court for the Eastern District of New York
• Represented a global lifestyle and consumer goods company in a putative stockholder class action in the Delaware Court of Chancery alleging material misstatements in proxy statement disclosures based on a recently enacted statute.  After winning summary judgment dismissing the case in its entirety in the trial court, Steve led the briefing on the subsequent appeal to the Delaware Supreme Court, which unanimously affirmed 
• Representing a publicly traded social media and technology company in arbitration and litigations in New York, Delaware, and Florida arising out of a de-SPAC transaction that closed in March 2024.  Most recently, Steve achieved complete victory for the client in a confidential arbitration involving the company’s chief adversary in the pending litigations  
• Represented a publicly traded biopharmaceutical company in litigation in the Delaware Court of Chancery seeking an order of specific performance requiring buyer to close a contemplated merger transaction.  Promptly after suit was filed, the buyer agreed to close on the same terms contemplated under the merger agreement  
• Representing a global IT services company in litigation pending in the US District Court for the Eastern District of Texas arising out of dispute concerning plaintiff’s entitlement to multimillion-dollar earnout payment under a merger agreement
• Representing a publicly traded banking institution in sprawling federal and state litigations arising out of a $100 million criminal check kiting, bank fraud, and money laundering scheme perpetrated by a former bank customer
• Representing a global IT services company in litigation against a Fortune 100 telecommunications company pending in the US District Court for the Southern District of New York arising out of the termination of a significant IT services contract

The Legal 500 United States

• Recommended, Securities Litigation – Defense, (2025)

Additional Recognitions 

• Rising Star, Business Litigation, Super Lawyers, (2020 – 2024)

^{For more information, pursuant to New Jersey Lawyer Advertising guidance, please click here.}